Literature DB >> 11904138

APOE genotype and hippocampal volume change in geriatric depression.

Do Hoon Kim1, Martha E Payne, Robert M Levy, James R MacFall, David C Steffens.   

Abstract

BACKGROUND: Apolipoprotein E has been associated with hippocampal volume loss in Alzheimer's disease and in elderly controls. In this study, we examined the role of apolipoprotein E and hippocampal volume change in 45 older nondemented depressed subjects. All had baseline and 2-year magnetic resonance imaging scans.
METHODS: Hippocampal volumes were determined using a semiautomated method.
RESULTS: Compared with 36 depressed subjects without an apolipoprotein E epsilon4 allele, 9 subjects with at least one APOE epsilon4 allele showed significant decline in hippocampal volume, particularly in the right hippocampus. In a logistic model, percent change in right hippocampal volume remained associated with presence of an APOE epsilon4 allele after controlling for age, gender, Mini-Mental State Examination score, and baseline total cerebral volume.
CONCLUSIONS: Future studies are needed to explain this association and to determine whether the finding for the right hippocampus has a biological basis, or if it is merely a function of small sample size.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11904138     DOI: 10.1016/s0006-3223(01)01272-0

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  11 in total

1.  Imbalanced hippocampal functional networks associated with remitted geriatric depression and apolipoprotein E ε4 allele in nondemented elderly: a preliminary study.

Authors:  Hao Shu; Yonggui Yuan; Chunming Xie; Feng Bai; Jiayong You; Lingjiang Li; Shi-Jiang Li; Zhijun Zhang
Journal:  J Affect Disord       Date:  2014-04-02       Impact factor: 4.839

Review 2.  Inflammation and depression: is there a causal connection with dementia?

Authors:  B E Leonard; A Myint
Journal:  Neurotox Res       Date:  2006-10       Impact factor: 3.911

Review 3.  Neuroimaging genomic studies in major depressive disorder: A systematic review.

Authors:  Hui-Feng Zhang; David Mellor; Dai-Hui Peng
Journal:  CNS Neurosci Ther       Date:  2018-02-23       Impact factor: 5.243

4.  Analysis of secondary phenotypes in multigroup association studies.

Authors:  Fan Zhou; Haibo Zhou; Tengfei Li; Hongtu Zhu
Journal:  Biometrics       Date:  2019-11-11       Impact factor: 2.571

5.  A cautionary note on using secondary phenotypes in neuroimaging genetic studies.

Authors:  Junghi Kim; Wei Pan
Journal:  Neuroimage       Date:  2015-07-26       Impact factor: 6.556

Review 6.  A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder.

Authors:  Margaret C McKinnon; Kaan Yucel; Anthony Nazarov; Glenda M MacQueen
Journal:  J Psychiatry Neurosci       Date:  2009-01       Impact factor: 6.186

7.  APOE ε4 associated with preserved executive function performance and maintenance of temporal and cingulate brain volumes in younger adults.

Authors:  Warren D Taylor; Brian Boyd; Rachel Turner; Douglas R McQuoid; Allison Ashley-Koch; James R MacFall; Ayman Saleh; Guy G Potter
Journal:  Brain Imaging Behav       Date:  2017-02       Impact factor: 3.978

8.  Structural plasticity of the adult brain: how animal models help us understand brain changes in depression and systemic disorders related to depression.

Authors:  Bruce S McEwen
Journal:  Dialogues Clin Neurosci       Date:  2004-06       Impact factor: 5.986

9.  Early-life stress leads to impaired spatial learning and memory in middle-aged ApoE4-TR mice.

Authors:  Lan-Yan Lin; Jing Zhang; Xiao-Man Dai; Nai-An Xiao; Xi-Lin Wu; Zhen Wei; Wen-Ting Fang; Yuan-Gui Zhu; Xiao-Chun Chen
Journal:  Mol Neurodegener       Date:  2016-07-12       Impact factor: 14.195

Review 10.  Aberrant Default Mode Network Underlying the Cognitive Deficits in the Patients With Late-Onset Depression.

Authors:  Xiaoyun Liu; Wenhao Jiang; Yonggui Yuan
Journal:  Front Aging Neurosci       Date:  2018-10-03       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.